US2420367A
(en)
*
|
1943-11-09 |
1947-05-13 |
Celanese Corp |
Fluffing up artificial staple fibers
|
US5206018A
(en)
*
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
DK520482A
(da)
*
|
1982-11-23 |
1984-05-24 |
Jacobsen P E B |
Sundhedsmadras
|
DK406686D0
(da)
*
|
1986-08-26 |
1986-08-26 |
Hans Bundgaard |
Carboxylsyrederivater
|
DE3853477T2
(de)
*
|
1987-12-09 |
1995-11-09 |
Fisons Plc |
Makrozyklische verbindungen.
|
GB8728820D0
(en)
*
|
1987-12-09 |
1988-01-27 |
Fisons Plc |
Compounds
|
EP0378318A1
(en)
*
|
1989-01-11 |
1990-07-18 |
Merck & Co. Inc. |
Process for synthesis of FK-506 and tricarbonyl intermediates
|
US4960790A
(en)
*
|
1989-03-09 |
1990-10-02 |
University Of Kansas |
Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
|
US5100899A
(en)
*
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
US5352671A
(en)
*
|
1989-11-09 |
1994-10-04 |
Sandoz Ltd. |
Heteroatoms-containing tricyclic compounds
|
NZ235991A
(en)
*
|
1989-11-09 |
1993-05-26 |
Sandoz Ltd |
Macrolide compounds and pharmaceutical compositions thereof
|
US5208228A
(en)
*
|
1989-11-13 |
1993-05-04 |
Merck & Co., Inc. |
Aminomacrolides and derivatives having immunosuppressive activity
|
JPH04230389A
(ja)
*
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
US5023264A
(en)
*
|
1990-07-16 |
1991-06-11 |
American Home Products Corporation |
Rapamycin oximes
|
US5120726A
(en)
*
|
1991-03-08 |
1992-06-09 |
American Home Products Corporation |
Rapamycin hydrazones
|
US5023263A
(en)
*
|
1990-08-09 |
1991-06-11 |
American Home Products Corporation |
42-oxorapamycin
|
US5023262A
(en)
*
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
US5221670A
(en)
*
|
1990-09-19 |
1993-06-22 |
American Home Products Corporation |
Rapamycin esters
|
PT98990A
(pt)
*
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
US5378696A
(en)
*
|
1990-09-19 |
1995-01-03 |
American Home Products Corporation |
Rapamycin esters
|
US5358944A
(en)
*
|
1990-09-19 |
1994-10-25 |
American Home Products Corporation |
Rapamycin esters for treating transplantation rejection
|
US5130307A
(en)
*
|
1990-09-28 |
1992-07-14 |
American Home Products Corporation |
Aminoesters of rapamycin
|
US5143918A
(en)
*
|
1990-10-11 |
1992-09-01 |
Merck & Co., Inc. |
Halomacrolides and derivatives having immunosuppressive activity
|
US5233036A
(en)
*
|
1990-10-16 |
1993-08-03 |
American Home Products Corporation |
Rapamycin alkoxyesters
|
US5120842A
(en)
*
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
*
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5194447A
(en)
*
|
1992-02-18 |
1993-03-16 |
American Home Products Corporation |
Sulfonylcarbamates of rapamycin
|
FI921595A
(fi)
*
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5147877A
(en)
*
|
1991-04-18 |
1992-09-15 |
Merck & Co. Inc. |
Semi-synthetic immunosuppressive macrolides
|
US5091389A
(en)
*
|
1991-04-23 |
1992-02-25 |
Merck & Co., Inc. |
Lipophilic macrolide useful as an immunosuppressant
|
US5138051A
(en)
*
|
1991-08-07 |
1992-08-11 |
American Home Products Corporation |
Rapamycin analogs as immunosuppressants and antifungals
|
US5102876A
(en)
*
|
1991-05-07 |
1992-04-07 |
American Home Products Corporation |
Reduction products of rapamycin
|
US5162334A
(en)
*
|
1991-05-13 |
1992-11-10 |
Merck & Co., Inc. |
Amino O-alkyl, O-alkenyl and O-alkynlmacrolides having immunosuppressive activity
|
US5565560A
(en)
*
|
1991-05-13 |
1996-10-15 |
Merck & Co., Inc. |
O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
|
US5776943A
(en)
*
|
1991-05-14 |
1998-07-07 |
American Home Products Corporation |
Rapamycin metabolites
|
US5118677A
(en)
*
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
EP0516347A1
(en)
*
|
1991-05-29 |
1992-12-02 |
American Home Products Corporation |
Rapamycin derivatives
|
EP0586512A1
(en)
*
|
1991-05-31 |
1994-03-16 |
Pfizer Inc. |
Use of rapamycin prodrugs as immunosuppressant agents
|
ZA924953B
(en)
*
|
1991-07-25 |
1993-04-28 |
Univ Louisville Res Found |
Method of treating ocular inflammation
|
US5189042A
(en)
*
|
1991-08-22 |
1993-02-23 |
Merck & Co. Inc. |
Fluoromacrolides having immunosuppressive activity
|
US5208241A
(en)
*
|
1991-09-09 |
1993-05-04 |
Merck & Co., Inc. |
N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity
|
US5162333A
(en)
*
|
1991-09-11 |
1992-11-10 |
American Home Products Corporation |
Aminodiesters of rapamycin
|
US5151413A
(en)
*
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5164399A
(en)
*
|
1991-11-18 |
1992-11-17 |
American Home Products Corporation |
Rapamycin pyrazoles
|
US5262424A
(en)
*
|
1992-02-18 |
1993-11-16 |
American Home Products Corporation |
Composition of sulfonylcarbamates of rapamycin and method of treating diseases requiring immunosuppression therewith
|
MX9301188A
(es)
*
|
1992-03-05 |
1994-07-29 |
American Home Prod |
Nuevos sulfonatos y 42-(n-carboalcoxi)sulfamatos en posicion 42 de la rapamicina, procedimiento para su preparacion y composicion farmaceutica que los comprende.
|
JP2741285B2
(ja)
*
|
1992-05-22 |
1998-04-15 |
千寿製薬株式会社 |
緑内障治療剤
|
ZA935111B
(en)
*
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
US5256790A
(en)
*
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
CA2106034A1
(en)
*
|
1992-09-24 |
1994-03-25 |
Ralph J. Russo |
21-norrapamycin
|
US5480989A
(en)
*
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5489680A
(en)
*
|
1992-10-13 |
1996-02-06 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5434260A
(en)
*
|
1992-10-13 |
1995-07-18 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5302584A
(en)
*
|
1992-10-13 |
1994-04-12 |
American Home Products Corporation |
Carbamates of rapamycin
|
US5480988A
(en)
*
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
EP0593227B1
(en)
*
|
1992-10-13 |
2006-03-22 |
Wyeth |
Carbamates of rapamycin
|
US5262423A
(en)
*
|
1992-10-29 |
1993-11-16 |
American Home Products Corporation |
Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
|
US5258389A
(en)
*
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US5260300A
(en)
*
|
1992-11-19 |
1993-11-09 |
American Home Products Corporation |
Rapamycin carbonate esters as immuno-suppressant agents
|
US5349060A
(en)
*
|
1993-01-07 |
1994-09-20 |
American Home Products Corporation |
Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
|
US5252579A
(en)
*
|
1993-02-16 |
1993-10-12 |
American Home Products Corporation |
Macrocyclic immunomodulators
|
US5310901A
(en)
*
|
1993-03-05 |
1994-05-10 |
Merck & Co., Inc. |
O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives
|
US5310903A
(en)
*
|
1993-03-05 |
1994-05-10 |
Merck & Co., Inc. |
Imidazolidyl rapamycin derivatives
|
USRE40596E1
(en)
*
|
1993-04-08 |
2008-12-02 |
Novartis Ag |
Rapamycin assay
|
GB9307491D0
(en)
|
1993-04-08 |
1993-06-02 |
Sandoz Ltd |
Organic compounds
|
US7279561B1
(en)
|
1993-04-23 |
2007-10-09 |
Wyeth |
Anti-rapamycin monoclonal antibodies
|
AU686629B2
(en)
|
1993-04-23 |
1998-02-12 |
Wyeth |
Rapamycin Conjugates and Antibodies
|
US5504091A
(en)
*
|
1993-04-23 |
1996-04-02 |
American Home Products Corporation |
Biotin esters of rapamycin
|
USRE37421E1
(en)
|
1993-07-16 |
2001-10-23 |
Smithkline Beecham Corporation |
Rapamycin derivatives
|
US5387680A
(en)
*
|
1993-08-10 |
1995-02-07 |
American Home Products Corporation |
C-22 ring stabilized rapamycin derivatives
|
US5373014A
(en)
*
|
1993-10-08 |
1994-12-13 |
American Home Products Corporation |
Rapamycin oximes
|
US5391730A
(en)
*
|
1993-10-08 |
1995-02-21 |
American Home Products Corporation |
Phosphorylcarbamates of rapamycin and oxime derivatives thereof
|
US5378836A
(en)
*
|
1993-10-08 |
1995-01-03 |
American Home Products Corporation |
Rapamycin oximes and hydrazones
|
US5527907A
(en)
*
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
US5385908A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Hindered esters of rapamycin
|
US5385910A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Gem-distributed esters of rapamycin
|
US5385909A
(en)
*
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Heterocyclic esters of rapamycin
|
US5389639A
(en)
*
|
1993-12-29 |
1995-02-14 |
American Home Products Company |
Amino alkanoic esters of rapamycin
|
US5362735A
(en)
*
|
1994-02-23 |
1994-11-08 |
Smithkline Beecham Corporation |
Rapamycin derivatives
|
US5525610A
(en)
*
|
1994-03-31 |
1996-06-11 |
American Home Products Corporation |
42-Epi-rapamycin and pharmaceutical compositions thereof
|
US5362718A
(en)
*
|
1994-04-18 |
1994-11-08 |
American Home Products Corporation |
Rapamycin hydroxyesters
|
US5463048A
(en)
*
|
1994-06-14 |
1995-10-31 |
American Home Products Corporation |
Rapamycin amidino carbamates
|
US5693648A
(en)
*
|
1994-09-30 |
1997-12-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity
|
US5491231A
(en)
*
|
1994-11-28 |
1996-02-13 |
American Home Products Corporation |
Hindered N-oxide esters of rapamycin
|
US5563145A
(en)
*
|
1994-12-07 |
1996-10-08 |
American Home Products Corporation |
Rapamycin 42-oximes and hydroxylamines
|
US5780462A
(en)
|
1995-12-27 |
1998-07-14 |
American Home Products Corporation |
Water soluble rapamycin esters
|
US5922730A
(en)
*
|
1996-09-09 |
1999-07-13 |
American Home Products Corporation |
Alkylated rapamycin derivatives
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
US7399480B2
(en)
|
1997-09-26 |
2008-07-15 |
Abbott Laboratories |
Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
|
US6890546B2
(en)
*
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
US20030129215A1
(en)
*
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
US20060198867A1
(en)
*
|
1997-09-25 |
2006-09-07 |
Abbott Laboratories, Inc. |
Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
|
US8057816B2
(en)
*
|
1997-09-26 |
2011-11-15 |
Abbott Laboratories |
Compositions and methods of administering paclitaxel with other drugs using medical devices
|
US8257726B2
(en)
*
|
1997-09-26 |
2012-09-04 |
Abbott Laboratories |
Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
|
US8394398B2
(en)
*
|
1997-09-26 |
2013-03-12 |
Abbott Laboratories |
Methods of administering rapamycin analogs with anti-inflammatories using medical devices
|
US7357942B2
(en)
*
|
1997-09-26 |
2008-04-15 |
Abbott Laboratories |
Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens
|
US7378105B2
(en)
*
|
1997-09-26 |
2008-05-27 |
Abbott Laboratories |
Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens
|
US8257725B2
(en)
*
|
1997-09-26 |
2012-09-04 |
Abbott Laboratories |
Delivery of highly lipophilic agents via medical devices
|
US6015809A
(en)
*
|
1998-08-17 |
2000-01-18 |
American Home Products Corporation |
Photocyclized rapamycin
|
US7960405B2
(en)
*
|
1998-09-24 |
2011-06-14 |
Abbott Laboratories |
Compounds and methods for treatment and prevention of diseases
|
US7455853B2
(en)
*
|
1998-09-24 |
2008-11-25 |
Abbott Cardiovascular Systems Inc. |
Medical devices containing rapamycin analogs
|
US20060240070A1
(en)
*
|
1998-09-24 |
2006-10-26 |
Cromack Keith R |
Delivery of highly lipophilic agents via medical devices
|
US8257724B2
(en)
*
|
1998-09-24 |
2012-09-04 |
Abbott Laboratories |
Delivery of highly lipophilic agents via medical devices
|
US6331547B1
(en)
|
1999-08-18 |
2001-12-18 |
American Home Products Corporation |
Water soluble SDZ RAD esters
|
US7807211B2
(en)
*
|
1999-09-03 |
2010-10-05 |
Advanced Cardiovascular Systems, Inc. |
Thermal treatment of an implantable medical device
|
US6790228B2
(en)
*
|
1999-12-23 |
2004-09-14 |
Advanced Cardiovascular Systems, Inc. |
Coating for implantable devices and a method of forming the same
|
US20070032853A1
(en)
*
|
2002-03-27 |
2007-02-08 |
Hossainy Syed F |
40-O-(2-hydroxy)ethyl-rapamycin coated stent
|
US6277983B1
(en)
|
2000-09-27 |
2001-08-21 |
American Home Products Corporation |
Regioselective synthesis of rapamycin derivatives
|
US6670355B2
(en)
|
2000-06-16 |
2003-12-30 |
Wyeth |
Method of treating cardiovascular disease
|
ATE278421T1
(de)
|
2000-08-11 |
2004-10-15 |
Wyeth Corp |
Verfahren zur behandlung eines östrogenrezeptor positives karzinoms
|
CA2421485A1
(en)
|
2000-09-19 |
2002-03-28 |
Wyeth |
Water soluble rapamycin esters
|
US6399625B1
(en)
|
2000-09-27 |
2002-06-04 |
Wyeth |
1-oxorapamycins
|
US6440991B1
(en)
|
2000-10-02 |
2002-08-27 |
Wyeth |
Ethers of 7-desmethlrapamycin
|
US6399626B1
(en)
|
2000-10-02 |
2002-06-04 |
Wyeth |
Hydroxyesters of 7-desmethylrapamycin
|
US20040018228A1
(en)
*
|
2000-11-06 |
2004-01-29 |
Afmedica, Inc. |
Compositions and methods for reducing scar tissue formation
|
US7829084B2
(en)
*
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
NZ528994A
(en)
*
|
2001-04-26 |
2006-02-24 |
Control Delivery Sys Inc |
Sustained release drug delivery system containing codrugs
|
US6641611B2
(en)
|
2001-11-26 |
2003-11-04 |
Swaminathan Jayaraman |
Therapeutic coating for an intravascular implant
|
US20040137066A1
(en)
*
|
2001-11-26 |
2004-07-15 |
Swaminathan Jayaraman |
Rationally designed therapeutic intravascular implant coating
|
US20080145402A1
(en)
*
|
2001-09-10 |
2008-06-19 |
Abbott Cardiovascular Systems Inc. |
Medical Devices Containing Rapamycin Analogs
|
IN2014DN10834A
(es)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
US6939376B2
(en)
|
2001-11-05 |
2005-09-06 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US7682387B2
(en)
*
|
2002-04-24 |
2010-03-23 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US20040024450A1
(en)
*
|
2002-04-24 |
2004-02-05 |
Sun Biomedical, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
UA82328C2
(uk)
|
2002-07-30 |
2008-04-10 |
Уайт |
Парентеральна композиція на основі гідроксіестеру рапаміцину (варіанти) та спосіб її приготування
|
AU2003218077B2
(en)
|
2002-09-06 |
2009-10-08 |
Abbott Laboratories |
Medical device having hydration inhibitor
|
EP2529758A3
(en)
*
|
2003-01-27 |
2013-01-02 |
Endocyte, Inc. |
Vitamin receptor binding drug delivery conjugates
|
US7160867B2
(en)
*
|
2003-05-16 |
2007-01-09 |
Isotechnika, Inc. |
Rapamycin carbohydrate derivatives
|
US20050118344A1
(en)
|
2003-12-01 |
2005-06-02 |
Pacetti Stephen D. |
Temperature controlled crimping
|
US8173840B2
(en)
*
|
2003-07-29 |
2012-05-08 |
Signature R&D Holdings, Llc |
Compounds with high therapeutic index
|
JP2007510621A
(ja)
*
|
2003-07-29 |
2007-04-26 |
シグニチャー アールアンドディー ホールディングス,エルエルシー. |
アミノ酸プロドラッグ
|
US7589233B2
(en)
*
|
2003-07-29 |
2009-09-15 |
Signature R&D Holdings, Llc |
L-Threonine derivatives of high therapeutic index
|
CN102144961A
(zh)
*
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
ATE534424T1
(de)
*
|
2004-03-19 |
2011-12-15 |
Abbott Lab |
Mehrfache arzneiabgabe aus einem ballon und eine prothese
|
US8431145B2
(en)
|
2004-03-19 |
2013-04-30 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
US20100030183A1
(en)
*
|
2004-03-19 |
2010-02-04 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using a coated balloon
|
US20070027523A1
(en)
*
|
2004-03-19 |
2007-02-01 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using coated balloon
|
SG152234A1
(en)
|
2004-04-14 |
2009-05-29 |
Wyeth Corp |
Regiospecific synthesis of rapamycin 42-ester derivatives
|
US7445916B2
(en)
*
|
2004-04-14 |
2008-11-04 |
Wyeth |
Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies
|
CN1946852A
(zh)
*
|
2004-04-27 |
2007-04-11 |
惠氏公司 |
利用雷帕霉素特异性甲基化酶标记雷帕霉素
|
EP1768692B8
(en)
*
|
2004-07-01 |
2015-06-17 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
EP1789391B1
(en)
|
2004-07-23 |
2017-06-28 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
US7901451B2
(en)
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
JP2008518966A
(ja)
*
|
2004-10-28 |
2008-06-05 |
ワイス |
子宮平滑筋腫の治療におけるmTOR阻害剤の使用
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
AU2006213673A1
(en)
|
2005-02-09 |
2006-08-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations for ocular treatment
|
GB0503936D0
(en)
*
|
2005-02-25 |
2005-04-06 |
San Raffaele Centro Fond |
Method
|
WO2006101845A2
(en)
*
|
2005-03-16 |
2006-09-28 |
Endocyte, Inc. |
Synthesis and purification of pteroic acid and conjugates thereof
|
US20090216317A1
(en)
*
|
2005-03-23 |
2009-08-27 |
Cromack Keith R |
Delivery of Highly Lipophilic Agents Via Medical Devices
|
WO2007032777A2
(en)
|
2005-03-23 |
2007-03-22 |
Abbott Laboratories |
Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy
|
DK2298815T3
(en)
|
2005-07-25 |
2015-06-15 |
Emergent Product Dev Seattle |
B-CELL REDUCTION USING CD37 SPECIFIC AND CD20 SPECIFIC BINDING MOLECULES
|
JP5475992B2
(ja)
*
|
2005-08-19 |
2014-04-16 |
エンドサイト,インコーポレイテッド |
多剤リガンド結合体
|
RU2451524C2
(ru)
|
2005-11-04 |
2012-05-27 |
Вайет |
Противоопухолевые комбинации с ингибиторами mtor, герцептином и/или hki-272
|
KR20080065704A
(ko)
|
2005-11-09 |
2008-07-14 |
콤비네이토릭스, 인코포레이티드 |
의학적 이상의 치료 방법들, 조성물들, 및 키트들
|
KR20080077989A
(ko)
*
|
2005-12-20 |
2008-08-26 |
와이어쓰 |
약물의 불순물 조절을 통한 cci-779 제형의 안정성 조절
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
US7622477B2
(en)
*
|
2006-02-28 |
2009-11-24 |
Cordis Corporation |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
|
US7678901B2
(en)
|
2006-02-28 |
2010-03-16 |
Wyeth |
Rapamycin analogs containing an antioxidant moiety
|
US20070203169A1
(en)
*
|
2006-02-28 |
2007-08-30 |
Zhao Jonathon Z |
Isomers and 42-epimers of rapamycin ester analogs, methods of making and using the same
|
KR101520408B1
(ko)
|
2006-03-23 |
2015-05-14 |
산텐 세이야꾸 가부시키가이샤 |
혈관 투과성-관련 질환 또는 상태를 위한 제형 및 방법
|
US20080051691A1
(en)
*
|
2006-08-28 |
2008-02-28 |
Wyeth |
Implantable shunt or catheter enabling gradual delivery of therapeutic agents
|
CN104906087A
(zh)
|
2006-09-13 |
2015-09-16 |
万能医药公司 |
大环内酯化合物及它们的使用方法
|
JP2010504974A
(ja)
|
2006-09-28 |
2010-02-18 |
フォリカ,インコーポレーテッド |
新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
US20080097591A1
(en)
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
US20100151436A1
(en)
*
|
2007-03-02 |
2010-06-17 |
Fong Peter M |
Methods for Ex Vivo Administration of Drugs to Grafts Using Polymeric Nanoparticles
|
JP5829793B2
(ja)
|
2007-03-14 |
2015-12-09 |
エンドサイト・インコーポレイテッドEndocyte, Inc. |
結合性リガンドが結合したツブリシンの薬剤送達結合体
|
TW200901989A
(en)
|
2007-04-10 |
2009-01-16 |
Wyeth Corp |
Anti-tumor activity of CCI-779 in papillary renal cell cancer
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
JP5690589B2
(ja)
|
2007-06-25 |
2015-03-25 |
エンドサイト・インコーポレイテッドEndocyte, Inc. |
親水性スペーサーリンカーを含有する結合体
|
BRPI0814060A2
(pt)
*
|
2007-07-06 |
2015-01-06 |
Trubion Pharmaceuticals Inc |
Peptídeos ligantes tendo um domínio de ligação específico disposto em c-terminal
|
CA2705764C
(en)
|
2007-11-14 |
2016-08-02 |
Biosensors International Group, Ltd. |
Automated stent coating apparatus and method
|
US20100048914A1
(en)
|
2008-03-14 |
2010-02-25 |
Angela Brodie |
Novel C-17-Heteroaryl Steroidal Cyp17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
|
JP5647098B2
(ja)
|
2008-03-21 |
2014-12-24 |
ザ ユニヴァーシティー オヴ シカゴ |
オピオイド拮抗薬とmTOR阻害薬を用いた治療
|
US20090253733A1
(en)
*
|
2008-04-02 |
2009-10-08 |
Biointeractions, Ltd. |
Rapamycin carbonate esters
|
NZ621443A
(en)
*
|
2008-04-11 |
2015-09-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
BRPI0919794A2
(pt)
*
|
2008-10-03 |
2015-12-15 |
Elixir Medical Corp |
dispositivo para uso intracorpóreo, e, composto
|
AU2010210422A1
(en)
|
2009-02-05 |
2011-08-18 |
Tokai Pharmaceuticals, Inc. |
Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
|
EP2416792A4
(en)
|
2009-04-10 |
2012-10-24 |
Haiyan Qi |
NEW ANTI-AGING APPROACHES AND METHOD FOR IDENTIFYING THEM
|
KR20120115237A
(ko)
|
2009-10-30 |
2012-10-17 |
어리어드 파마슈티칼스, 인코포레이티드 |
암 치료 방법 및 조성물
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
US20110144577A1
(en)
*
|
2009-12-11 |
2011-06-16 |
John Stankus |
Hydrophilic coatings with tunable composition for drug coated balloon
|
US8480620B2
(en)
*
|
2009-12-11 |
2013-07-09 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable solubility profile for drug-coated balloon
|
US8951595B2
(en)
*
|
2009-12-11 |
2015-02-10 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable molecular architecture for drug-coated balloon
|
JP2013521002A
(ja)
|
2010-03-05 |
2013-06-10 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
誘導樹状細胞組成物及びその使用
|
EP2532740A1
(en)
|
2011-06-11 |
2012-12-12 |
Michael Schmück |
Antigen-specific CD4+ and CD8+ central-memory T cell preparations for adoptive T cell therapy
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
ES2574522T3
(es)
|
2012-06-08 |
2016-06-20 |
Biotronik Ag |
Ésteres 40-O-hidrocarburo cíclico de rapamicina, composiciones y procedimientos
|
BR112015008365A2
(pt)
|
2012-10-16 |
2017-07-04 |
Endocyte Inc |
composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente
|
WO2014068070A1
(en)
|
2012-10-31 |
2014-05-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for preventing antiphospholipid syndrome (aps)
|
KR20150127720A
(ko)
|
2013-03-14 |
2015-11-17 |
유니버시티 오브 매릴랜드, 발티모어 |
안드로겐 수용체 하향 조절제 및 그의 용도
|
US9539217B2
(en)
|
2013-04-03 |
2017-01-10 |
Allertein Therapeutics, Llc |
Nanoparticle compositions
|
US9808472B2
(en)
|
2013-08-12 |
2017-11-07 |
Tokai Pharmaceuticals, Inc. |
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
|
CN105461738B
(zh)
*
|
2014-06-03 |
2019-03-08 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种雷帕霉素衍生物、其制备方法、其药物组合物及用途
|
CN113620978A
(zh)
|
2014-09-11 |
2021-11-09 |
加利福尼亚大学董事会 |
mTORC1抑制剂
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
WO2019002168A1
(en)
|
2017-06-26 |
2019-01-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OLMSTED SYNDROME
|
JP2020527044A
(ja)
|
2017-07-13 |
2020-09-03 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
CD8+CD45RCLOW/−Treg集団の拡大増殖および免疫抑制能力を高めるための方法
|
AR112834A1
(es)
|
2017-09-26 |
2019-12-18 |
Novartis Ag |
Derivados de rapamicina
|
MX2020011565A
(es)
|
2018-05-01 |
2021-01-29 |
Revolution Medicines Inc |
Analogos de rapamicina ligados a c40, c28 y c-32 como inhibidores de mtor.
|
EP3788050A1
(en)
|
2018-05-01 |
2021-03-10 |
Revolution Medicines, Inc. |
C26-linked rapamycin analogs as mtor inhibitors
|
CN113164563A
(zh)
|
2018-07-23 |
2021-07-23 |
因柯利尔疗法公司 |
神经性病症的治疗方法
|
CN113164557A
(zh)
|
2018-07-23 |
2021-07-23 |
因柯利尔疗法公司 |
治疗神经性病症的方法
|
EP3849545A1
(en)
|
2018-09-10 |
2021-07-21 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Methods for the treatment of neurofibromatosis
|
CA3136648A1
(en)
|
2019-04-11 |
2020-10-15 |
Enclear Therapies, Inc. |
Methods of amelioration of cerebrospinal fluid and devices and systems therefor
|
WO2024008799A1
(en)
|
2022-07-06 |
2024-01-11 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the treatment of proliferative glomerulonephritis
|
WO2024028433A1
(en)
|
2022-08-04 |
2024-02-08 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the treatment of lymphoproliferative disorders
|